This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Osella, G. Articles by Angeli, A. Search for Related Content PubMed PubMed Citation Articles by Osella, G. Articles by Angeli, A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Adrenal Gland Cancer Cushing's Syndrome

Serum Markers of Bone and Collagen Turnover in Patients with Cushing’s Syndrome and in Subjects with Adrenal Incidentalomas

Dipartimento di Scienze Cliniche e Biologiche, Cattedra di Medicina Interna, Azienda Ospedaliera S. Luigi, Università di Torino, Torino, Italy

Address all correspondence and requests for reprints to: Dr. Giangiacomo Osella, Clinica Medica Generale, Azienda Ospedaliera S. Luigi, Regione Gonzole 10, 10043 Orbassano (TO), Italy.

The aim of this study was to assess serum levels of some markers of bone turnover and collagen synthesis in 22 patients with adrenal incidentalomas (AI), a model of silent glucocorticoid excess, and to compare the results with those obtained in 18 patients with Cushing’s syndrome (CS). Osteocalcin (BGP), bone isoenzyme of alkaline phosphatase, carboxy-terminal propeptide of type I procollagen, and carboxy-terminal cross-linked telopeptide of type I collagen were measured as biochemical indexes of bone turnover, and amino-terminal propeptide of type III procollagen was determined as an index of collagen synthesis. Two groups of healthy volunteers evenly matched for sex, age, and menstrual status were used for a case-control analysis of AI and CS groups, respectively. Patients with AI showed a slight, albeit significant, reduction in serum BGP and a mild increase in carboxy-terminal cross-linked telopeptide of type I collagen levels compared with controls [median, 6.6 vs. 7.8 ng/mL (P < 0.05) and 4.2 vs. 3.1 µg/L (P < 0.01), respectively]. No significant differences were found when comparing the other markers. Patients with CS had BGP, bone isoenzyme of alkaline phosphatase, and amino-terminal propeptide of type III procollagen levels significantly lower than control values [median, 3.0 vs. 7.3 ng/mL (P < 0.0001); 4.4 vs. 11.5 µg/L (P < 0.01); 2.2 vs. 4.3 µg/L (P < 0.0001), respectively], but no significant difference in the other markers.

These results confirm a clear inhibition of osteoblastic activity in CS and could suggest an enhanced bone metabolism in patients with AI. The degree of impairment of bone turnover in patients with AI does not seem enough to recommend surgery (removal of the adrenal adenoma) in the absence of other indications.

This article has been cited by other articles:

				C. Kristo, R. Jemtland, T. Ueland, K. Godang, and J. Bollerslev Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study Eur. J. Endocrinol., January 1, 2006; 154(1): 109 - 118. [Abstract] [Full Text] [PDF]

				G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman, et al. Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5593 - 5602. [Abstract] [Full Text] [PDF]

				L. Tauchmanova, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.-A. Palmieri, S. Fazio, and G. Lombardi Patients with Subclinical Cushing's Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4872 - 4878. [Abstract] [Full Text] [PDF]

				G. Osella, G. Reimondo, P. Peretti, A. Alì, P. Paccotti, A. Angeli, and M. Terzolo The Patients with Incidentally Discovered Adrenal Adenoma (Incidentaloma) Are Not at Increased Risk of Osteoporosis J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 604 - 607. [Abstract] [Full Text]

				R. Rossi, L. Tauchmanova, A. Luciano, M. Di Martino, C. Battista, L. Del Viscovo, V. Nuzzo, and G. Lombardi Subclinical Cushing's Syndrome in Patients with Adrenal Incidentaloma: Clinical and Biochemical Features J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1440 - 1448. [Abstract] [Full Text]

				F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A. M. Masini, A. Alì, M. Giovagnetti, G. Opocher, and A. Angeli A Survey on Adrenal Incidentaloma in Italy J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 637 - 644. [Abstract] [Full Text]

				M. Torlontano, I. Chiodini, M. Pileri, G. Guglielmi, M. Cammisa, S. Modoni, V. Carnevale, V. Trischitta, and A. Scillitani Altered Bone Mass and Turnover in Female Patients with Adrenal Incidentaloma: The Effect of Subclinical Hypercortisolism J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2381 - 2385. [Abstract] [Full Text]

				A. Sartorio and A. Conti Bone and Collagen Turnover in Patients with Active and Preclinical Cushing's Syndrome and in Subjects with Adrenal Incidentaloma J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2605 - 2605. [Full Text]

				G. Osella, M. Terzolo, and G. Reimondo Bone and Collagen Turnover in Patients with Active and Preclinical Cushing's Syndrome and in Subjects with Adrenal Incidentaloma--Authors' Response J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2605a - 2606. [Full Text]

				I. Chiodini, V. Carnevale, M. Torlontano, S. Fusilli, G. Guglielmi, M. Pileri, S. Modoni, A. Di Giorgio, A. Liuzzi, S. Minisola, et al. Alterations of Bone Turnover and Bone Mass at Different Skeletal Sites due to Pure Glucocorticoid Excess: Study in Eumenorrheic Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1863 - 1867. [Abstract] [Full Text]